About this Journal Publication ethics Editorial Board Editorial Council Editorial Office For the Authors Contacts
English

News feeds

Journal in Databases

eLIBRARY.RU - НАУЧНАЯ ЭЛЕКТРОННАЯ БИБЛИОТЕКА

Google Scholar

Google Scholar

For authors' attention

Publication is free of charge

In aims to provide interconnection of publications in international scientific journals using Digital Object Identification - DOI, our editorial office incorporated the journal "Social aspects of population health" into international reference system CrossRef.

Since 2016 DOI will be assigned to all scientific articles published in our journal free of charge.

Also DOI will be assigned to all articles published in 2014 and 2015 free of charge as well
Main arrow Archive of previous Issues arrow №6 2013 (34) arrow Problems of prostate cancer screening induced by comprehensive medical examination in the Russian Federation
Problems of prostate cancer screening induced by comprehensive medical examination in the Russian Federation Print
Thursday, 26 December 2013

O.I. Apolikhin1, M.I. Katibov1, A.V. Sivkov1, I.V. Chernishev1, D.A. Roschin1, I.A. Shaderkin1, N.G. Moskaleva1, G.D. Efremov1, V.M. Kuraeva2
1Research Institute of Urology of Ministry of Health of the Russian Federation;
2Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Abstract. The aim of the study was to predict problems of prostate cancer screening that could be induced by comprehensive medical examination of the Russian population. For that purpose current state of the art of the healthcare system was analyzed. The analysis identified the following issues of concern: lack of a universal standard of screening test performance – blood test for prostatic specific antigen, insufficient sensitivity and specificity of this test, sharp increase in demand for prostate biopsy, shortage of qualified staff, poor material and technical resources of health care facilities, overdiagnosis and over treatment. It is calculated that comprehensive medical examination can detect about 173589 new case of prostate cancer per year, which is six times higher when usually diagnosed without comprehensive medical examination – 28552 cases. Expenses for detection, staging and treatment of prostate cancer as a result of comprehensive medical examination can add up to 15.7 billion rubles per year. Therefore, to reduce implications of the comprehensive medical examination it is crucial to proactively conduct personnel training and improve material and technical resources of health care facilities, to apply the principle of “risk groups selection” during implementation of comprehensive medical examination and employ step-wise approach for care delivery on the basis of clinical and financial feasibility of each step.

To exemplify application of those principles to improve efficiency of screening programs the authors refer to the subprogram “Urology” developed by the Research Institute of Urology under the “Healthcare development in Voronezh region in 2011-2015” program.

Key words: screening; population survey; prostate cancer; prostate specific antigen; prostate biopsy.

References

  1. Malignancies in Russia in 2011 (morbidity and mortality). Chissov VI, Starinskiy VV, Petrova GV, editors. Moscow: P.A. Gertsen Research Oncological Institute of the Ministry of Health of the Russian Federation; 2013. 289 p. (In Russian).
  2. The results of All-Russian population census 2010. [Internet ]. [Cited 2013 Jul 19]. Available from: http://www.gks.ru/free_doc/new_site/perepis2010/croc/perepis_itogi1612.htm (In Russian).
  3. Maksimov VA, Pushkar' DYu, Umarov MS. The current view on the problem of screening for prostates cancer. Urologiya. 2009; (5): 74-77. (In Russian).
  4. The main directions of the budgetary policy for 2013 and the planning period of 2014 and 2015. [Internet]. [Cited 2013 Feb 03] Available from: http://minfin.ru/ru/reforms/budget/results/ (In Russian).
  5. On approving the clinical examination in the certain adult population groups: the Order of the Ministry of Health of the Russian Federation №1006n of December 3, 2012 [Internet]. 2012 [cited 2013 Jul 01]. Available from: http://www.rg.ru/2013/04/25/dispanserizaciya-dok.html (In Russian).
  6. Krivonos OV, Skachkova EI, Malkhasyan VA, Pushkar' DYu. The current status, problems, and futures of the development of urological service in Russia. Urologiya. 2012; (5): 5-12. (In Russian).
  7. Tariffs for medical service 2013. [Internet]. [Cited 2013 Sep 05] Available from: http://www.skfoms.ru/tarifimeduslugi/866--2013- (In Russian).
  8. Fletcher R, Fletcher S, Vagner E. Clinical epidemiology. The basics of evidence – based medicine. [Transl. from English.] Moscow: Media- sfera; 2004. 352 p.
  9. Gilbert SM, Cavallo CB, Kahane H, Lowe FC. Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: review of 36,316 biopsies. Urology. 2005; 65 (3): 549-553.
  10. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J. Clin. Oncol. 2010; 28(6): 1069-1074.
  11. La Rochelle J, Amling CL. Prostate cancer screening: what we have learned from the PLCO and ERSPC trials. Curr. Urol. Rep. 2010; 11(3): 198-201.
  12. Andriole G.L., Crawford E.D., Grubb R.L. III, Buys S.S., Chia D., Church T.R., et al. Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 2009; 360(13): 1310–1319.
  13. Schroder FH, Hugosson J, Roobol MJ, Tammela T.L., Ciatto S., Nelen V., et al. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 2009; 360(13): 1320-1328.
  14. Eckersberger E, Finkelstein J, Sadri H, Margreiter M, Taneja SS, Lepor H, et al. Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. Rev. Urol. 2009;11(3): 127-133.

Views: 15696

Comments (1)
1. 16-01-2014 10:42
Очень качественный и нужный, хотя и запоздалый анализ. 
Одно замечание. Авторы пишут: "Верхний предел возраста в 75 лет был нами выбран с учетом того, что у мужчин старше 75 лет не рекомендуется проведение скрининга РПЖ". 
Но ведь программой диспансеризации (Приказ МЗ №1006н от 03.12.2012) при проведении скрининга РПЖ предел возраста установлен в 100 лет. Следовательно, выявляемость РПЖ может вырасти не в 6, а в значительно большее число раз.  
И одно предложение. 
Авторам статьи следует направить на имя министра здравоохранения это исследование и официальное письмо НИИ Урологии с предложением исключить скрининг РПЖ из программы диспансеризации.
Written by Валерий Алексеевич ( This e-mail address is being protected from spam bots, you need JavaScript enabled to view it ) (Guest)

Write Comment
  • Please keep the topic of messages relevant to the subject of the article.
  • Personal verbal attacks will be deleted.
  • Please don't use comments to plug your web site. Such material will be removed.
  • Just ensure to *Refresh* your browser for a new security code to be displayed prior to clicking on the 'Send' button.
  • Keep in mind that the above process only applies if you simply entered the wrong security code.
Name:
E-mail
Comment:

Code:* Code

Last Updated ( Wednesday, 15 January 2014 )
Next >
home contact search contact search